CDKN2A/p16, RB and CDK4 alterations in osteosarcoma.

被引：0
|
作者：
Nielsen, GP
Burns, K
Rosenberg, AE
Louis, DN
机构：
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA
[2] Univ Ottawa, Ottawa, ON, Canada
来源：
LABORATORY INVESTIGATION | 1998年 / 78卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
55
引用
收藏
页码：13A / 13A
页数：1
相关论文
共 50 条
  • [1] CDKN2A/p16, RB and CDK4 alterations in osteosarcoma
    Nielsen, GP
    Burns, K
    Rosenberg, AE
    Louis, DN
    [J]. MODERN PATHOLOGY, 1998, 11 (01) : 13A - 13A
  • [2] Retinoblastoma tumors lacking identified RB1 alterations do not carry mutations in p16/CDKN2A or CDK4, other elements of the pRB pathway.
    Benoit, E
    Tsao, H
    Dryja, TP
    Haluska, FG
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A61 - A61
  • [3] CDKN2A/p16 Loss Implicates CDK4 as a Therapeutic Target in Imatinib-Resistant Dermatofibrosarcoma Protuberans
    Eilers, Grant
    Czaplinski, Jeffrey T.
    Mayeda, Mark
    Bahri, Nacef
    Tao, Derrick
    Zhu, Meijun
    Hornick, Jason L.
    Lindeman, Neal I.
    Sicinska, Ewa
    Wagner, Andrew J.
    Fletcher, Jonathan A.
    Marino-Enriquez, Adrian
    [J]. MOLECULAR CANCER THERAPEUTICS, 2015, 14 (06) : 1346 - 1353
  • [4] CDKN2A/p16 in ependymomas
    Simona Bortolotto
    Loredana Chiadò-Piat
    Paola Cavalla
    Ivana Bosone
    Alessandro Mauro
    Davide Schiffer
    [J]. Journal of Neuro-Oncology, 2001, 54 : 9 - 13
  • [5] CDKN2A/p16 in ependymomas
    Bortolotto, S
    Chiadò-Piat, L
    Cavalla, P
    Bosone, I
    Mauro, A
    Schiffer, D
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2001, 54 (01) : 9 - 13
  • [6] Alteration of pRb/p16/cdk4 regulation in human osteosarcoma
    Benassi, MS
    Molendini, L
    Gamberi, G
    Ragazzini, P
    Sollazzo, MR
    Merli, M
    Asp, J
    Magagnoli, G
    Balladelli, A
    Bertoni, F
    Picci, P
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1999, 84 (05) : 489 - 493
  • [7] CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations
    Nielsen, GP
    Burns, KL
    Rosenberg, AE
    Louis, DN
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (01): : 159 - 163
  • [8] Human glioblastomas with no alterations of the CDKN2A (p16(INK4A), MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene
    Ichimura, K
    Schmidt, EE
    Goike, HM
    Collins, VP
    [J]. ONCOGENE, 1996, 13 (05) : 1065 - 1072
  • [9] PD 0332991, a selective CDK4/6 inhibitor, preferentially inhibits growth of ovarian cancer cells with high Rb and low p16 (CDKN2A) expression
    Konecny, G.
    Winterhoff, B.
    Manivong, K.
    Qi, J.
    Kolarova, T.
    Kalli, K.
    Hartmann, L.
    Cliby, W.
    Finkler, N.
    Slamon, D.
    [J]. GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S138 - S139
  • [10] Frequent alterations in p16/CDKN2A identified by immunohistochemistry and FISH in chordoma
    Cottone, Lucia
    Eden, Nadia
    Usher, Inga
    Lombard, Patrick
    Ye, Hongtao
    Ligammari, Lorena
    Lindsay, Daniel
    Brandner, Sebastian
    Pizem, Joze
    Pillay, Nischalan
    Tirabosco, Roberto
    Amary, Fernanda
    Flanagan, Adrienne M.
    [J]. JOURNAL OF PATHOLOGY CLINICAL RESEARCH, 2020, 6 (02): : 113 - 123
12345